vs
Side-by-side financial comparison of HARTE HANKS INC (HHS) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.
Phathom Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($57.6M vs $39.9M, roughly 1.4× HARTE HANKS INC). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs -15.4%). HARTE HANKS INC produced more free cash flow last quarter ($-686.0K vs $-167.0M).
Harte Hanks is a global marketing services company headquartered in Boston, Massachusetts. Harte Hanks services include analytics, strategy, marketing technology, creative services, digital marketing, customer care, direct mail, logistics, and fulfillment.
Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.
HHS vs PHAT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $39.9M | $57.6M |
| Net Profit | $2.2M | — |
| Gross Margin | — | 86.7% |
| Operating Margin | -0.3% | — |
| Net Margin | 5.5% | — |
| Revenue YoY | -15.4% | 94.1% |
| Net Profit YoY | — | 71.6% |
| EPS (diluted) | $0.30 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $39.9M | $57.6M | ||
| Q3 25 | $39.5M | $49.5M | ||
| Q2 25 | $38.6M | $39.5M | ||
| Q1 25 | $41.6M | $28.5M | ||
| Q4 24 | $47.1M | $29.7M | ||
| Q3 24 | $47.6M | $16.4M | ||
| Q2 24 | $45.0M | $7.3M | ||
| Q1 24 | $45.4M | — |
| Q4 25 | $2.2M | — | ||
| Q3 25 | $-2.3M | $-30.0M | ||
| Q2 25 | $-335.0K | $-75.8M | ||
| Q1 25 | $-392.0K | $-94.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | $142.0K | $-85.6M | ||
| Q2 24 | $-27.8M | $-91.4M | ||
| Q1 24 | $-171.0K | — |
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 87.5% | ||
| Q2 25 | — | 87.2% | ||
| Q1 25 | — | 86.9% | ||
| Q4 24 | — | 87.1% | ||
| Q3 24 | — | 85.6% | ||
| Q2 24 | — | 81.2% | ||
| Q1 24 | — | — |
| Q4 25 | -0.3% | — | ||
| Q3 25 | 1.3% | -30.8% | ||
| Q2 25 | 0.1% | -151.7% | ||
| Q1 25 | -0.1% | -276.5% | ||
| Q4 24 | -3.3% | — | ||
| Q3 24 | 4.0% | -433.0% | ||
| Q2 24 | 3.0% | -1055.4% | ||
| Q1 24 | 0.8% | — |
| Q4 25 | 5.5% | — | ||
| Q3 25 | -5.8% | -60.5% | ||
| Q2 25 | -0.9% | -191.9% | ||
| Q1 25 | -0.9% | -330.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.3% | -523.3% | ||
| Q2 24 | -61.8% | -1248.6% | ||
| Q1 24 | -0.4% | — |
| Q4 25 | $0.30 | — | ||
| Q3 25 | $-0.31 | $-0.41 | ||
| Q2 25 | $-0.05 | $-1.05 | ||
| Q1 25 | $-0.05 | $-1.31 | ||
| Q4 24 | $-0.31 | — | ||
| Q3 24 | $0.02 | $-1.32 | ||
| Q2 24 | $-3.84 | $-1.56 | ||
| Q1 24 | $-0.02 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.6M | $130.0M |
| Total DebtLower is stronger | — | $209.1M |
| Stockholders' EquityBook value | $20.5M | $-438.2M |
| Total Assets | $91.8M | $259.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.6M | $130.0M | ||
| Q3 25 | $6.5M | $135.2M | ||
| Q2 25 | $4.8M | $149.6M | ||
| Q1 25 | $9.0M | $212.3M | ||
| Q4 24 | $9.8M | $297.3M | ||
| Q3 24 | $5.9M | $334.7M | ||
| Q2 24 | $11.0M | $276.2M | ||
| Q1 24 | $11.5M | — |
| Q4 25 | — | $209.1M | ||
| Q3 25 | — | $207.1M | ||
| Q2 25 | — | $205.1M | ||
| Q1 25 | — | $203.2M | ||
| Q4 24 | — | $201.4M | ||
| Q3 24 | — | $175.7M | ||
| Q2 24 | — | $174.4M | ||
| Q1 24 | — | — |
| Q4 25 | $20.5M | $-438.2M | ||
| Q3 25 | $19.9M | $-422.5M | ||
| Q2 25 | $22.2M | $-405.8M | ||
| Q1 25 | $21.4M | $-338.4M | ||
| Q4 24 | $21.7M | $-253.6M | ||
| Q3 24 | $21.0M | $-187.1M | ||
| Q2 24 | $20.6M | $-233.8M | ||
| Q1 24 | $20.0M | — |
| Q4 25 | $91.8M | $259.1M | ||
| Q3 25 | $92.7M | $240.3M | ||
| Q2 25 | $95.0M | $250.2M | ||
| Q1 25 | $100.6M | $294.2M | ||
| Q4 24 | $101.8M | $378.3M | ||
| Q3 24 | $108.1M | $387.0M | ||
| Q2 24 | $109.7M | $319.4M | ||
| Q1 24 | $113.4M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $737.0K | $-166.8M |
| Free Cash FlowOCF − Capex | $-686.0K | $-167.0M |
| FCF MarginFCF / Revenue | -1.7% | -290.0% |
| Capex IntensityCapex / Revenue | 3.6% | 0.4% |
| Cash ConversionOCF / Net Profit | 0.33× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-4.5M | $-328.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $737.0K | $-166.8M | ||
| Q3 25 | $3.2M | $-14.1M | ||
| Q2 25 | $-4.8M | $-62.7M | ||
| Q1 25 | $-818.0K | $-84.9M | ||
| Q4 24 | $4.0M | $-266.8M | ||
| Q3 24 | $-2.9M | $-63.6M | ||
| Q2 24 | $1.6M | $-70.7M | ||
| Q1 24 | $-5.7M | — |
| Q4 25 | $-686.0K | $-167.0M | ||
| Q3 25 | $2.2M | $-14.1M | ||
| Q2 25 | $-5.1M | $-62.8M | ||
| Q1 25 | $-923.0K | $-84.9M | ||
| Q4 24 | $3.4M | $-266.9M | ||
| Q3 24 | $-4.9M | $-63.6M | ||
| Q2 24 | $926.0K | $-70.8M | ||
| Q1 24 | $-6.2M | — |
| Q4 25 | -1.7% | -290.0% | ||
| Q3 25 | 5.5% | -28.6% | ||
| Q2 25 | -13.1% | -159.0% | ||
| Q1 25 | -2.2% | -297.9% | ||
| Q4 24 | 7.3% | -899.8% | ||
| Q3 24 | -10.2% | -389.0% | ||
| Q2 24 | 2.1% | -966.2% | ||
| Q1 24 | -13.7% | — |
| Q4 25 | 3.6% | 0.4% | ||
| Q3 25 | 2.5% | 0.1% | ||
| Q2 25 | 0.6% | 0.2% | ||
| Q1 25 | 0.3% | 0.1% | ||
| Q4 24 | 1.3% | 0.5% | ||
| Q3 24 | 4.0% | 0.3% | ||
| Q2 24 | 1.5% | 0.6% | ||
| Q1 24 | 1.2% | — |
| Q4 25 | 0.33× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -20.76× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HHS
| Fulfillment And Logistics Services | $17.3M | 43% |
| Customer Care | $13.7M | 34% |
| Other | $8.9M | 22% |
PHAT
Segment breakdown not available.
